Double-Blind, Randomized Study Of The Analgesic Efficacy And Safety Of Valdecoxib 20 Mg Daily And Valdecoxib 20 Mg Twice Daily Compared To Placebo For Management Of Acute Postsurgical Pain In Anterior Cruciate Ligament (ACL) Reconstruction
Public ClinicalTrials.gov record NCT00650039. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Double-Blind, Placebo-Controlled, Randomized Study Of The Analgesic Efficacy And Safety Of Valdecoxib 20 Mg QD And Valdecoxib 20 Mg BID Compared To Placebo Over Multiple Days For Management Of Acute Postsurgical Pain In Patients Undergoing Anterior Cruciate Ligament Reconstruction
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective was to evaluate the analgesic efficacy of valdecoxib 20 mg daily and valdecoxib 20 mg twice daily compared with placebo in outpatients with moderate-severe pain after arthroscopic anterior cruciate ligament (ACL) reconstruction surgery. Secondary objectives were to compare each valdecoxib dose with placebo on additional measures of pain intensity, health outcomes, the use of rescue medication, and the occurrence of opioid-related symptoms, and to evaluate their safety.
Study identification
- NCT ID
- NCT00650039
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 488 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2004 (Type not available)
- Primary completion
- Not listed
- Completion
- Feb 2005 (Actual)
- Last update posted
- Jun 4, 2008
2004 – 2005
United States locations
- U.S. sites
- 68
- U.S. states
- 17
- U.S. cities
- 49
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Birmingham | Alabama | 35205 | — |
| Pfizer Investigational Site | Birmingham | Alabama | 36205 | — |
| Pfizer Investigational Site | Northport | Alabama | 35476 | — |
| Pfizer Investigational Site | Glendale | Arizona | 85310 | — |
| Pfizer Investigational Site | Pheonix | Arizona | 85006 | — |
| Pfizer Investigational Site | Pheonix | Arizona | 85008 | — |
| Pfizer Investigational Site | Pheonix | Arizona | 85016 | — |
| Pfizer Investigational Site | Phoenix | Arizona | 85016 | — |
| Pfizer Investigational Site | Phoenix | Arizona | 85032 | — |
| Pfizer Investigational Site | Tempe | Arizona | 85281 | — |
| Pfizer Investigational Site | Glendale | California | 91206 | — |
| Pfizer Investigational Site | Laguna Hills | California | 92653 | — |
| Pfizer Investigational Site | Laguna Woods | California | 92653 | — |
| Pfizer Investigational Site | Los Angeles | California | 90045 | — |
| Pfizer Investigational Site | Avon | Connecticut | 06001 | — |
| Pfizer Investigational Site | Cromwell | Connecticut | 06416 | — |
| Pfizer Investigational Site | Enfield | Connecticut | 06082 | — |
| Pfizer Investigational Site | Farmington | Connecticut | 06030 | — |
| Pfizer Investigational Site | Farmington | Connecticut | 06032 | — |
| Pfizer Investigational Site | Glastonbury | Connecticut | 06033 | — |
| Pfizer Investigational Site | Hartford | Connecticut | 06102 | — |
| Pfizer Investigational Site | Hartford | Connecticut | 06106 | — |
| Pfizer Investigational Site | Rocky Hill | Connecticut | 06067 | — |
| Pfizer Investigational Site | Windsor | Connecticut | 06095 | — |
| Pfizer Investigational Site | Hollywood | Florida | 33021 | — |
| Pfizer Investigational Site | Jacksonville | Florida | 32216 | — |
| Pfizer Investigational Site | Jacksonville | Florida | 32250 | — |
| Pfizer Investigational Site | Plantation | Florida | 33324 | — |
| Pfizer Investigational Site | Saint Augustine | Florida | 32086 | — |
| Pfizer Investigational Site | St. Petersburg | Florida | 33703 | — |
| Pfizer Investigational Site | Weston | Florida | 33326 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30327 | — |
| Pfizer Investigational Site | Morrow | Georgia | 30260 | — |
| Pfizer Investigational Site | Stockbridge | Georgia | 30281 | — |
| Pfizer Investigational Site | Chicago | Illinois | 60304 | — |
| Pfizer Investigational Site | Chicago | Illinois | 60612 | — |
| Pfizer Investigational Site | Oak Park | Illinois | 60304 | — |
| Pfizer Investigational Site | Cedar Rapids | Iowa | 52401 | — |
| Pfizer Investigational Site | Lexington | Kentucky | 40504 | — |
| Pfizer Investigational Site | Lexington | Kentucky | 40509 | — |
| Pfizer Investigational Site | Baltimore | Maryland | 21218 | — |
| Pfizer Investigational Site | Timonium | Maryland | 21093 | — |
| Pfizer Investigational Site | Royal Oak | Michigan | 48073 | — |
| Pfizer Investigational Site | Troy | Michigan | 48085 | — |
| Pfizer Investigational Site | Springfield | Missouri | 65804 | — |
| Pfizer Investigational Site | Springfield | Missouri | 65807 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89106 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89117 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89121 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89144 | — |
| Pfizer Investigational Site | Bend | Oregon | 97701 | — |
| Pfizer Investigational Site | Anderson | South Carolina | 29621 | — |
| Pfizer Investigational Site | Cola | South Carolina | 29212 | — |
| Pfizer Investigational Site | Columbia | South Carolina | 29202 | — |
| Pfizer Investigational Site | Columbia | South Carolina | 29204 | — |
| Pfizer Investigational Site | Orangeburg | South Carolina | 29110 | — |
| Pfizer Investigational Site | Austin | Texas | 78705 | — |
| Pfizer Investigational Site | Dallas | Texas | 75231 | — |
| Pfizer Investigational Site | Fort Worth | Texas | 76104 | — |
| Pfizer Investigational Site | Fort Worth | Texas | 76107 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78127 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78209 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78217 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78229 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78240 | — |
| Pfizer Investigational Site | San Marcos | Texas | 78666 | — |
| Pfizer Investigational Site | Arlington | Virginia | 22205 | — |
| Pfizer Investigational Site | Fairfax | Virginia | 22031 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00650039, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 4, 2008 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00650039 live on ClinicalTrials.gov.